Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Friday, March 14, 2014

FDA Approves Mercka s NOXAFIL (posaconazole) Injection (18 mg/mL) for Intravenous Use

Merck's antifungal agent is also marketed as NOXAFIL delayed-release tablets and NOXAFIL oral suspension.

http://ift.tt/NeaMjA

No comments:

Post a Comment

Popular Stem Cell Roundup Posts